The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.85
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.399%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 49.85
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IP Group FY profits more than double

Wed, 16th Mar 2022 07:25

(Sharecast News) - Intellectual property company IP Group said on Wednesday that full-year profits had more than doubled following solid increases in both its net asset and total portfolio values.

IP Group stated full-year after-tax profits had surged 142% to £449.3m, driven by a "strong performance" across all sectors, while its net asset value had increased 30% to £1.73bn and its total portfolio value grew 27% to £1.5bn. Cash realisations of £213.4m were up 11.7%.

As a result of the solid performance, IP Group recommended a final dividend of 0.72p per share, which, when including the £27.2m of shares bought back by the firm in its buyback programme to date, meant that it had returned £42.8m in total capital to shareholders in 2021.

The FTSE 250-listed firm also highlighted its "sustained investment" in its portfolio, with the group pouring £103.7m into 65 different companies in 2021, up from £67.5m in 2020.

Chief executive Greg Smith said: "2021 was a landmark year for IP Group as we celebrated our 20th anniversary by recording our best set of financial results to date, including record profits, cash realisations, portfolio investment, and a return on NAV of almost half-a-billion pounds.

"Science as a driver for innovation is now widely understood and there is widespread recognition that scientific solutions, and the new technologies they inspire, are needed to address the major challenges facing the world. IP Group's strategy is to increasingly focus on companies tackling those challenges and contribute to a more sustainable, healthier future that is enriched by technological advances."

More News
6 Jan 2021 09:07

IP Group Invests GBP4.0 Million In Oxbotica Series B Funding Round

IP Group Invests GBP4.0 Million In Oxbotica Series B Funding Round

Read more
6 Jan 2021 08:25

IP Group's Oxbiotica raises £36m in series B round

(Sharecast News) - Intellectual property investor IP Group announced on Wednesday that its autonomous vehicle software portfolio company Oxbotica has raised £36m of new capital in a series B round, from both new and existing investors.

Read more
3 Dec 2020 09:58

IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA

IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA

Read more
3 Dec 2020 09:08

IP Group's Artios signs research deal with Merck

(Sharecast News) - IP Group said its Artios portfolio company had signed a research deal with Merck of Germany that could more than double the value of the investment company's stake.

Read more
13 Oct 2020 10:37

UK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale

UK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale

Read more
13 Oct 2020 09:58

IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress

IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress

Read more
13 Oct 2020 08:30

IP Group portfolio firm Oxford Nanopore raises another £84.4m

(Sharecast News) - Intellectual property-based business investor IP Group announced on Tuesday that its portfolio company Oxford Nanopore Technologies has raised an additional £84.4m of new capital from existing and new investors, including International Holdings Company (IHC) and RPMI Railpen.

Read more
9 Oct 2020 10:37

IP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test

IP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test

Read more
7 Oct 2020 10:57

IP Group portfolio business offloads cystic fibrosis treatment programme to Roche

(Sharecast News) - Intellectual property company IP Group said on Wednesday that portfolio group Enterprise Therapeutics' TMEM16A cystic fibrosis treatment programme had been acquired by Swiss pharmaceutical giant Roche.

Read more
7 Oct 2020 08:55

TOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy

TOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy

Read more
7 Oct 2020 07:54

LONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers

LONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers

Read more
7 Oct 2020 07:40

LONDON MARKET PRE-OPEN: Tesco Lifts Interim Payout 21% As Profit Rises

LONDON MARKET PRE-OPEN: Tesco Lifts Interim Payout 21% As Profit Rises

Read more
10 Aug 2020 09:43

UK BROKER RATINGS SUMMARY: RBC Upgrades Hastings To Sector Perform

UK BROKER RATINGS SUMMARY: RBC Upgrades Hastings To Sector Perform

Read more
6 Aug 2020 09:38

UK BROKER RATINGS SUMMARY: Liberum Says Buy XP Power, Cuts PageGroup

UK BROKER RATINGS SUMMARY: Liberum Says Buy XP Power, Cuts PageGroup

Read more
5 Aug 2020 11:04

IP Group Net Asset Value Declines Amid Record Cash Realisations

IP Group Net Asset Value Declines Amid Record Cash Realisations

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.